TRPV1 and asthma: This exposure significantly upregulated TRPV1 or TRPA1 in lung tissue, exacerbating asthma-like pathological features, which could be alleviated by using TRPV1 antagonists such as capsazepine or TRPA1 antagonists like HC030031 (Du et al., 2019; Lu et al., 2023; Deng et al., 2024).